GLP-1s aren't FDA-approved to treat rheumatoid arthritis, but many people notice improvement in their inflammation with the ...

Cassandra Smith has rheumatoid arthritis (RA) and knows all too well how debilitating the autoimmune condition can be. Her ...

The FDA just approved the SetPoint System, which electrically stimulates the vagus nerve to control inflammation from the ...

Medical professionals observe that GLP-1 medications like Ozempic show promise for treating rheumatoid arthritis alongside ...

A new nanoparticle drug has shown preclinical promise in both preventing rheumatoid arthritis and reducing painful flare-ups, offering hope for a targeted, steroid-sparing treatment that calms the ...

A team of scientists from Japan has identified hidden immune ‘hubs’ that drive joint damage in patients with rheumatoid ...

SaveHealth reports arthritis affects millions, involving joint inflammation and pain. Various types exist, with treatment ...

Medically reviewed by David Ozeri, MD Rheumatoid arthritis (RA) can make tasks like getting dressed, typing, or gripping certain objects hard to manage. When joint pain, stiffness, and swelling get in ...

JAK inhibitors for rheumatoid arthritis demonstrate higher risks for cancer vs. biologic disease-modifying antirheumatic drugs, particularly among older patients and those with higher disease activity ...

More than 8 in 10 patients with rheumatoid arthritis were taking 5 or more medications at once, a practice linked to older ...

Over time, rheumatoid arthritis can affect other parts of your body such as your heart, lungs, and blood vessels. The active ingredient in Xeljanz is tofacitinib, which is a JAK inhibitor.

A cross-sectional study of RA patients in India finds 34.5% suffer from methotrexate intolerance, with symptoms often ...